Patients with PTEN mutations have an increased risk of breast cancer, thyroid cancer, melanoma and endometrial cancer [52, 53], and recently, Peterman et al. found that patients with somatic PIK3CA mutations had an increased risk of Wilms tumour [54]. The gene discussed is PTEN; the disease is thyroid cancer.